Back
Amicus Therapeutics Stock Predictions
Sponsored
FOLD
Sponsored
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
FOLD
Amicus Therapeutics
Last Price:
10.71
Seasonality Move:
-8.45%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!Amicus Therapeutics Stock Forecast
- Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 13.8% based on the past 17 years of stock performance.
- Amicus Therapeutics has risen higher in 7 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.18%
-
Is Amicus Therapeutics Stock Undervalued?
The current Amicus Therapeutics [FOLD] share price is $10.71. The Score for FOLD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 13.8% based on the past 17 years of stock performance.
Amicus Therapeutics Stock Rating
Sell
45
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics overpriced?
- Amicus Therapeutics has risen higher in 7 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.18%
Amicus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
14.57
52-Week Low:
9.02
Prediction Charts
Market Cap:
3.18B
Price in USD:
10.71
Volume:
1.67M
Beta:
1.02
Technical Analysis
SMA50:
11.05
SMA100:
10.52
SMA200:
11.43
52-Wk Change:
-16.85%
Stock Predictions
-
Is Amicus Therapeutics stock public?
Yes, Amicus Therapeutics is a publicly traded company. -
What is the Amicus Therapeutics stock quote today?
The Amicus Therapeutics stock price is 10.71 USD today. -
How to buy Amicus Therapeutics stock online?
You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-10 | 11.50 | 11.25 | 11.51 | 11.25 |
Sep-11 | 11.17 | 11.27 | 11.32 | 11.15 |
Sep-12 | 11.25 | 11.29 | 11.36 | 11.10 |
Sep-13 | 11.35 | 11.30 | 11.42 | 11.21 |
Sep-16 | 11.34 | 11.06 | 11.36 | 11.02 |
Sep-17 | 11.14 | 11.20 | 11.37 | 11.05 |
Sep-18 | 11.16 | 10.91 | 11.26 | 10.89 |
Sep-19 | 11.13 | 11.00 | 11.17 | 10.98 |
Sep-20 | 11.03 | 11.29 | 11.34 | 10.77 |
Sep-23 | 11.36 | 11.22 | 11.42 | 11.03 |
Sep-24 | 11.20 | 11.22 | 11.35 | 11.04 |
Sep-25 | 11.19 | 10.88 | 11.24 | 10.82 |
Sep-26 | 11.01 | 10.72 | 11.01 | 10.44 |
Sep-27 | 10.83 | 10.71 | 10.87 | 10.62 |
Amicus Therapeutics Earnings
Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics Forecast Revenue Growth
Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.51 per share, and an increase next year of $0.29 per share.
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.